- cafead Feb 06, 2021 at 11:02: PM
via Merck KGaA agreed to speed up the supply of lipids to BioNTech SE, easing a bottleneck preventing faster production of Covid-19 vaccines.
The German pharma company is already looking to expand production of custom lipids and expects to increase deliveries to BioNTech toward the end of 2021, it said in a statement Friday.
article source
The German pharma company is already looking to expand production of custom lipids and expects to increase deliveries to BioNTech toward the end of 2021, it said in a statement Friday.
article source